DAIICHI SANKYO
Daiichi Sankyo Company, Limited engages in the research, development, manufacture, import, sale, and marketing of pharmaceutical products. The company offers prescription drugs, OTC drugs, and quasi-drugs. Its principal products include Olmetec, Rezaltas, Calblock, and Mevalotin for cardiovascular diseases; Cravit for infectious diseases; Loxonin for bone/joint diseases; and Urief for urological diseases. The company also offers vaccines. In addition, the company is developing products for vario... us diseases, which are under various clinical trial stages. Further, it manufactures and sells cosmetics, medical equipment, food, and beverages, as well as veterinary medicines; and manufactures active pharmaceutical ingredients and intermediates. Daiichi Sankyo primarily operates in Japan, North America, Europe, and India. The company is headquartered in Tokyo, Japan.
DAIICHI SANKYO
Social Links:
Industry:
Biotechnology Health Care
Founded:
2005-01-01
Address:
Parsippany, New Jersey, United States
Country:
United States
Website Url:
http://www.daiichisankyo.com
Total Employee:
10001+
Status:
Active
Contact:
+81362251111
Technology used in webpage:
LetsEncrypt Domain Not Resolving Nginx CloudFront Facebook Domain Insights Hubspot Apple Whitelist Amazon Oregon Region Intercom Apollo GraphQL
Similar Organizations
CO2 Solutions
Nature's Power for Carbon Capture / La puissance de la nature pour la capture du carbone.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-10-08 | Im Co., Ltd. | Im Co., Ltd. acquired by Daiichi Sankyo | N/A |
| 2014-09-29 | Ambit Biosciences | Ambit Biosciences acquired by Daiichi Sankyo | 410 M USD |
| 2011-02-28 | Plexxikon | Plexxikon acquired by Daiichi Sankyo | 935 M USD |
| 2008-11-01 | Ranbaxy Laboratories | Ranbaxy Laboratories acquired by Daiichi Sankyo | 4.6 B USD |
| 2008-05-21 | U3 Pharma | U3 Pharma acquired by Daiichi Sankyo | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-07-20 | Cuorips, Inc. | Daiichi Sankyo investment in Venture Round - Cuorips, Inc. | 1000 M JPY |
| 2017-08-07 | Cuorips, Inc. | Daiichi Sankyo investment in Seed Round - Cuorips, Inc. | 100 M JPY |
| 2013-02-14 | Orphan Disease Treatment Institute | Daiichi Sankyo investment in Pre Seed Round - Orphan Disease Treatment Institute | 165 M JPY |
| 2012-01-01 | Coherus Biosciences | Daiichi Sankyo investment in Series B - Coherus Biosciences | 61.5 M USD |
| 2005-10-18 | SymBio Pharmaceuticals | Daiichi Sankyo investment in Series A - SymBio Pharmaceuticals | N/A |
Official Site Inspections
http://www.daiichisankyo.com Semrush global rank: 1.32 M Semrush visits lastest month: 22.29 K
- Host name: 20.44.154.140
- IP address: 20.44.154.140
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
